Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.

[1]  E. Noordijk,et al.  European Organization for Research and Treatment of Cancer (EORTC) and International Society for Cutaneous Lymphoma (ISCL) consensus recommendations for the management of cutaneous B-cell lymphomas Short title for running head: management of cutaneous B-cell lymphoma , 2008 .

[2]  M. Trautmann,et al.  Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection , 1994, Journal of clinical microbiology.

[3]  T. Barbui,et al.  Preventing Fungal Infection in Neutropenic Patients with Acute Leukemia: Fluconazole Compared with Oral Amphotericin B , 1994, Annals of Internal Medicine.

[4]  T. Walsh,et al.  Evolving risk factors for invasive fungal infections--all neutropenic patients are not the same. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  W. Fibbe,et al.  Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  J. Niland,et al.  Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Wingard,et al.  Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients , 1993, Antimicrobial Agents and Chemotherapy.

[8]  H. Horowitz,et al.  Fluconazole Prophylaxis of Fungal Infections in Patients with Acute Leukemia: Results of a Randomized Placebo-Controlled, Double-Blind, Multicenter Trial , 1993, Annals of Internal Medicine.

[9]  J. L. Goodman,et al.  A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. , 1992, The New England journal of medicine.

[10]  R. Finberg,et al.  Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  M G Rinaldi,et al.  Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. , 1991, The New England journal of medicine.

[12]  T. Lister,et al.  Myeloablative therapy for follicular lymphoma. , 1991, Hematology/oncology clinics of North America.

[13]  C. Viscoli,et al.  Fluconazole in the treatment of candidiasis in immunocompromised children , 1991, Antimicrobial Agents and Chemotherapy.

[14]  F. Meunier.  Fluconazole treatment of fungal infections in the immunocompromised host. , 1990, Seminars in oncology.

[15]  J. Karp,et al.  From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel. , 1990, The Journal of infectious diseases.

[16]  H. Gallis,et al.  Amphotericin B: 30 years of clinical experience. , 1990, Reviews of infectious diseases.

[17]  R. Mayer,et al.  The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. , 1988, Archives of internal medicine.

[18]  R. Myerowitz,et al.  Disseminated candidiasis. Changes in incidence, underlying diseases, and pathology. , 1977, American journal of clinical pathology.

[19]  J. Aisner,et al.  Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. , 1977, Annals of internal medicine.

[20]  J. Cuttner,et al.  Fungal infection in acute leukemia , 1972, Cancer.

[21]  L. Young,et al.  Infectious complications of neoplastic disease. , 1971, The Medical clinics of North America.

[22]  G. Bodey.  Fungal infections complicating acute leukemia. , 1966, Journal of chronic diseases.

[23]  F. Meunier.  Empirical antifungal therapy in febrile granulocytopenic patients , 1989 .

[24]  F. Witebsky,et al.  Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. , 1982, The American journal of medicine.

[25]  H. Braine,et al.  The clinical significance and management of fever in acute myelocytic leukemia. , 1976, The Johns Hopkins medical journal.